Publications

Filters: Keyword is Cytotoxicity, Immunologic  [Clear All Filters]
1999
Helfand SC, Dickerson EB, Munson KL, Padilla ML.  1999.  GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.. Cancer research. 59(13):3119-27. Abstract
1996
Helfand SC, Hank JA, Gan J, Sondel PM.  1996.  Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.. Cellular immunology. 167(1):99-107. Abstract
1995
Helfand SC, Modiano JF, Moore PF, Soergel SA, MacWilliams PS, Dubielzig RD, Hank JA, Gelfand EW, Sondel PM.  1995.  Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphoma.. Blood. 86(2):636-45. Abstract
1994
Helfand SC, Soergel SA, Modiano JF, Hank JA, Sondel PM.  1994.  Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro.. Cancer biotherapy. 9(3):237-44. Abstract
Helfand SC, Soergel SA, MacWilliams PS, Hank JA, Sondel PM.  1994.  Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.. Cancer immunology, immunotherapy : CII. 39(2):84-92. Abstract
1993
Cuff CF, Cebra CK, Rubin DH, Cebra JJ.  1993.  Developmental relationship between cytotoxic alpha/beta T cell receptor-positive intraepithelial lymphocytes and Peyer's patch lymphocytes.. European journal of immunology. 23(6):1333-9. Abstract